speb/financial-data huggingface dataset:
CBAN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 225188000.00
CBAN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CBAN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CBAN income_statement (annual, 2025-12-31) — Pretax Income: 35135000.00
CBAN income_statement (quarterly, 2025-12-31) — Pretax Income: 9553000.00
CBAN income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 3507000.00
CBAN income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 1019000.00
CBAN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -22703000.00
CBAN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 8268000.00
CBAN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1354000.00
CBAN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -572000.00
CBAN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 7723000.00
CBAN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2304000.00
CBAN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -275000000.00
CBAN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -50000000.00
CBAN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2368000.00
CBAN cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -779000.00
CBAN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 2063000.00
CBAN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 1331000.00
CBAN balance_sheet (annual, 2025-12-31) — Retained Earnings: 160584000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 160584000.00
CBAN income_statement (annual, 2025-12-31) — Salaries And Wages: 52417000.00
CBAN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 14115000.00
CBAN cash_flow (annual, 2025-12-31) — Sale Of Business: 916000.00
CBAN cash_flow (annual, 2025-12-31) — Sale Of Investment: 156407000.00
CBAN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 11762000.00
CBAN cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
CBAN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CBAN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 4279000.00
CBAN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1402000.00
CBAN income_statement (annual, 2025-12-31) — Selling General And Administration: 56696000.00
CBAN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 15517000.00
CBAN balance_sheet (annual, 2025-12-31) — Share Issued: 21251695.00
CBAN balance_sheet (quarterly, 2025-12-31) — Share Issued: 21251695.00
CBAN income_statement (annual, 2025-12-31) — Special Income Charges: -2063000.00
CBAN income_statement (quarterly, 2025-12-31) — Special Income Charges: -1331000.00
CBAN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 785000.00
CBAN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 211000.00
CBAN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 375920000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 375920000.00
CBAN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 304196000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 304196000.00
CBAN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -405585.80
CBAN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -238250.81
CBAN income_statement (annual, 2025-12-31) — Tax Provision: 6882000.00
CBAN income_statement (quarterly, 2025-12-31) — Tax Provision: 1710000.00
CBAN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
CBAN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
CBAN balance_sheet (annual, 2025-12-31) — Total Assets: 3735401000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Total Assets: 3735401000.00
CBAN balance_sheet (annual, 2025-12-31) — Total Capitalization: 634024000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 634024000.00
CBAN balance_sheet (annual, 2025-12-31) — Total Debt: 258104000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Total Debt: 258104000.00
CBAN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 375920000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 375920000.00
CBAN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3359481000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3359481000.00
CBAN income_statement (annual, 2025-12-31) — Total Unusual Items: -2063000.00
CBAN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1331000.00
CBAN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2063000.00
CBAN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1331000.00
CBAN income_statement (quarterly, 2026-03-31) — +Total Revenue: 39895000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 227071000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 186249000.00
CBAN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 21222237.00
CBAN income_statement (quarterly, 2026-03-31) — Basic EPS: 0.39
CBAN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 257640000.00
CBAN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -421000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 21162000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 295806000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 295806000.00
CBAN cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2551000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Cash Financial: 24349000.00
CBAN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -23442000.00
CBAN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 7355000.00
CBAN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 54253000.00
CBAN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 11000.00
CBAN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 296000.00
CBAN cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -479000.00
CBAN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -172000.00
CBAN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 38166000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Common Stock: 21162000.00
CBAN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2551000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 380403000.00
CBAN cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1766000.00
CBAN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 359000.00
CBAN cash_flow (quarterly, 2026-03-31) — Deferred Tax: 359000.00
CBAN cash_flow (quarterly, 2026-03-31) — Depreciation: 3188000.00
CBAN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3188000.00
CBAN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3188000.00
CBAN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 21222237.00
CBAN income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.39
CBAN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8204000.00
CBAN cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -36000.00
CBAN cash_flow (quarterly, 2026-03-31) — End Cash Position: 295806000.00
CBAN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -23442000.00
CBAN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 53832000.00
CBAN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -10000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -34067000.00
CBAN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 15923000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Goodwill: 63047000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 70443000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 371918000.00
CBAN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 19000.00
CBAN income_statement (quarterly, 2026-03-31) — Interest Expense: 15687000.00
CBAN income_statement (quarterly, 2026-03-31) — Interest Income: 44890000.00
CBAN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 14931000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 638540000.00
CBAN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 7355000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 766544000.00
CBAN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 50000000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 258137000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 258137000.00
CBAN cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 50000000.00
CBAN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -50000000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1766000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8204000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8204000.00
CBAN income_statement (quarterly, 2026-03-31) — Net Interest Income: 29203000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 22456000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -23000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 653000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Net PPE: 36842000.00
CBAN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -394000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 309960000.00
CBAN income_statement (quarterly, 2026-03-31) — Normalized Income: 9487408.00
CBAN income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 1957000.00
CBAN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 54253000.00
CBAN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1008000.00
CBAN income_statement (quarterly, 2026-03-31) — Operating Revenue: 39895000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 21162104.00
CBAN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -34067000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 7396000.00
CBAN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 41739000.00
CBAN income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 5931000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 208377000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CBAN income_statement (quarterly, 2026-03-31) — Pretax Income: 10471000.00
CBAN income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 1120000.00
CBAN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4825000.00
CBAN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -421000.00
CBAN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3188000.00
CBAN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -50000000.00
CBAN cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1766000.00
CBAN income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 1637000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 166237000.00
CBAN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 15923000.00
CBAN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 27281000.00
CBAN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 27000.00
CBAN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1106000.00
CBAN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17029000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Share Issued: 21162104.00
CBAN income_statement (quarterly, 2026-03-31) — Special Income Charges: -1637000.00
CBAN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 193000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 380403000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 309960000.00
CBAN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -353592.00
CBAN income_statement (quarterly, 2026-03-31) — Tax Provision: 2267000.00
CBAN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
CBAN balance_sheet (quarterly, 2026-03-31) — Total Assets: 3720613000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 638540000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Total Debt: 258137000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 380403000.00
CBAN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3340210000.00
CBAN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1637000.00
CBAN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1637000.00
CBAN income_statement (quarterly, 2026-06-30) — Basic Average Shares: 21160128.00
CBAN income_statement (quarterly, 2026-06-30) — Basic EPS: 0.51
CBAN income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 21160128.00
CBAN income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.51
CBAT cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -7464067.00
CBAT cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -505998.00
CBAT cash_flow (annual, 2021-12-31) — Change In Tax Payable: -7464067.00
CBAT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 65495011.00
CBAT balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 597944.00
CBAT balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Non Current: 62941.00
CBAT balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 326507.00
CBAT cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -61802000.00
CBAT income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 61802000.00
CBAT balance_sheet (annual, 2021-12-31) — Goodwill: 1645232.00
CBAT income_statement (annual, 2021-12-31) — Interest Income: 784880.00
CBAT income_statement (annual, 2021-12-31) — Interest Income Non Operating: 784880.00
CBAT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 65495011.00
CBAT balance_sheet (annual, 2021-12-31) — Loans Receivable: 0.00
CBAT cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 65495011.00
CBAT balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 62941.00
CBAT balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 0.00
CBAT balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 1403813.00
CBAT balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 1403813.00
CBAT balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 5846000.00
CBAT balance_sheet (annual, 2021-12-31) — Other Investments: 838528.00
CBAT income_statement (annual, 2021-12-31) — Provision For Doubtful Accounts: -780389.00
CBAT cash_flow (annual, 2021-12-31) — Sale Of Investment: 3100.00
CBAT balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 0.00
CBAT income_statement (annual, 2022-12-31) — +Operating Expense: 22381009.00
CBAT income_statement (annual, 2022-12-31) — +Total Revenue: 248725485.00
CBAT balance_sheet (annual, 2022-12-31) — Accounts Payable: 32516445.00
CBAT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 21148220.00
CBAT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -35957608.00
CBAT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 246240998.00
CBAT balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2274513.00
CBAT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 8046218.00
CBAT income_statement (annual, 2022-12-31) — Basic Average Shares: 88927671.00
CBAT income_statement (annual, 2022-12-31) — Basic EPS: -0.11
CBAT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 26354624.00
CBAT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 47086680.00
CBAT cash_flow (annual, 2022-12-31) — Capital Expenditure: -12373112.00
CBAT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2027015.00
CBAT balance_sheet (annual, 2022-12-31) — Capital Stock: 89135.00
CBAT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 6519212.00
CBAT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 6519212.00
CBAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5611372.00
CBAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -7928246.00
CBAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 15114814.00
CBAT cash_flow (annual, 2022-12-31) — Change In Account Payable: 7557193.00
CBAT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 581074.00
CBAT cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -109307.00
CBAT cash_flow (annual, 2022-12-31) — Change In Inventory: -23977795.00
CBAT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1539120.00
CBAT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 1188476.00
CBAT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -4757674.00
CBAT cash_flow (annual, 2022-12-31) — Change In Payable: 7447886.00
CBAT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 8028960.00
CBAT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 7146992.00
CBAT cash_flow (annual, 2022-12-31) — Change In Receivables: 21021110.00
CBAT cash_flow (annual, 2022-12-31) — Change In Tax Payable: -109307.00
CBAT cash_flow (annual, 2022-12-31) — Change In Working Capital: 10189189.00
CBAT cash_flow (annual, 2022-12-31) — Changes In Cash: 12797940.00
CBAT balance_sheet (annual, 2022-12-31) — Common Stock: 89135.00
CBAT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 117495374.00
CBAT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Construction In Progress: 9954202.00
CBAT income_statement (annual, 2022-12-31) — Cost Of Revenue: 230630161.00
CBAT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6648505.00
CBAT balance_sheet (annual, 2022-12-31) — Current Assets: 125707008.00
CBAT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1419793.00
CBAT balance_sheet (annual, 2022-12-31) — Current Debt: 15596971.00
CBAT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 17016764.00
CBAT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 6929097.00
CBAT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 6929097.00
CBAT balance_sheet (annual, 2022-12-31) — Current Liabilities: 111933857.00
CBAT balance_sheet (annual, 2022-12-31) — Current Provisions: 26215.00
CBAT cash_flow (annual, 2022-12-31) — Depreciation: 8559023.00
CBAT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 8559023.00
CBAT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 8559023.00
CBAT income_statement (annual, 2022-12-31) — Diluted Average Shares: 88927671.00
CBAT income_statement (annual, 2022-12-31) — Diluted EPS: -0.11
CBAT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -9448446.00
CBAT balance_sheet (annual, 2022-12-31) — Dividends Payable: 1290942.00
CBAT balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Non Current: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 358067.00
CBAT income_statement (annual, 2022-12-31) — EBIT: -4285685.00
CBAT income_statement (annual, 2022-12-31) — EBITDA: 4273338.00
CBAT income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 0.00
CBAT cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
CBAT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1796488.00
CBAT cash_flow (annual, 2022-12-31) — End Cash Position: 37356076.00
CBAT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 5611372.00
CBAT balance_sheet (annual, 2022-12-31) — Finished Goods: 25070832.00
CBAT cash_flow (annual, 2022-12-31) — Free Cash Flow: 2741702.00
CBAT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -5710000.00
CBAT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CBAT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 7722451.00
CBAT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 5710000.00
CBAT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6923133.00
CBAT income_statement (annual, 2022-12-31) — General And Administrative Expense: 9737711.00
CBAT balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 13670221.00
CBAT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 23422733.00
CBAT balance_sheet (annual, 2022-12-31) — Gross PPE: 137180897.00
CBAT income_statement (annual, 2022-12-31) — Gross Profit: 18095324.00
CBAT income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 6387786.00
CBAT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 59508.00
CBAT income_statement (annual, 2022-12-31) — Interest Income: 491060.00
CBAT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 491060.00
CBAT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 571118.00
CBAT balance_sheet (annual, 2022-12-31) — Inventory: 49446291.00
CBAT balance_sheet (annual, 2022-12-31) — Invested Capital: 133092345.00
CBAT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -7928246.00
CBAT balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 945237.00
CBAT balance_sheet (annual, 2022-12-31) — Investments And Advances: 945237.00
CBAT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CBAT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 24567951.00
CBAT balance_sheet (annual, 2022-12-31) — Leases: 5156705.00
CBAT balance_sheet (annual, 2022-12-31) — Line Of Credit: 14907875.00
CBAT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 607222.00
CBAT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 607222.00
CBAT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1486679.00
CBAT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -628122.00
CBAT balance_sheet (annual, 2022-12-31) — Long Term Provisions: 450613.00
CBAT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 73718750.00
CBAT balance_sheet (annual, 2022-12-31) — Minority Interest: 6883123.00
CBAT income_statement (annual, 2022-12-31) — Minority Interests: 1879365.00
CBAT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 4162702.00
CBAT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Net Debt: 9077759.00
CBAT income_statement (annual, 2022-12-31) — Net Income: -9448446.00
CBAT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -9448446.00
CBAT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -11327811.00
CBAT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -9448446.00
CBAT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -9448446.00
CBAT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -11327811.00
CBAT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -11327811.00
CBAT income_statement (annual, 2022-12-31) — Net Interest Income: 491060.00
CBAT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4124693.00
CBAT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 858557.00
CBAT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 491060.00
CBAT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 1486679.00
CBAT balance_sheet (annual, 2022-12-31) — Net PPE: 101223289.00
CBAT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -12090948.00
CBAT cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 3266136.00
CBAT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 103825153.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 1085525.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 2486979.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5577020.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 5577020.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2486979.00
CBAT balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 0.00
CBAT income_statement (annual, 2022-12-31) — Normalized EBITDA: 5782256.00
CBAT income_statement (annual, 2022-12-31) — Normalized Income: -8087127.63
CBAT balance_sheet (annual, 2022-12-31) — Notes Receivable: 6265355.00
CBAT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 15114814.00
CBAT cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2012451.00
CBAT income_statement (annual, 2022-12-31) — Operating Income: -4285685.00
CBAT income_statement (annual, 2022-12-31) — Operating Revenue: 248725485.00
CBAT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 88990858.00
CBAT balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 689096.00
CBAT balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 136000.00
CBAT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6923133.00
CBAT balance_sheet (annual, 2022-12-31) — Other Equity Interest: 14101689.00
CBAT income_statement (annual, 2022-12-31) — Other Gand A: 9737711.00
CBAT income_statement (annual, 2022-12-31) — Other Income Expense: -8761393.00
CBAT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 13670221.00
CBAT balance_sheet (annual, 2022-12-31) — Other Investments: 0.00
CBAT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -7252475.00
CBAT balance_sheet (annual, 2022-12-31) — Other Payable: 47369889.00
CBAT balance_sheet (annual, 2022-12-31) — Other Properties: 1264560.00
CBAT balance_sheet (annual, 2022-12-31) — Other Receivables: 6183449.00
CBAT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
CBAT balance_sheet (annual, 2022-12-31) — Payables: 81177276.00
CBAT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 87825781.00
CBAT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1022601.00
CBAT income_statement (annual, 2022-12-31) — Pretax Income: -12556018.00
CBAT balance_sheet (annual, 2022-12-31) — Properties: 0.00
CBAT income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 831132.00
CBAT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -2428449.00
CBAT cash_flow (annual, 2022-12-31) — Purchase Of Business: -297336.00
CBAT cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CBAT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -12373112.00
CBAT balance_sheet (annual, 2022-12-31) — Raw Materials: 7101426.00
CBAT balance_sheet (annual, 2022-12-31) — Receivables: 37882040.00
CBAT balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -7000.00
CBAT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 230630161.00
CBAT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 8559023.00
CBAT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -20443258.00
CBAT income_statement (annual, 2022-12-31) — Research And Development: 10635486.00
CBAT balance_sheet (annual, 2022-12-31) — Restricted Cash: 30836864.00
CBAT balance_sheet (annual, 2022-12-31) — Retained Earnings: -131946705.00
CBAT cash_flow (annual, 2022-12-31) — Sale Of Business: 4460038.00
CBAT cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CBAT cash_flow (annual, 2022-12-31) — Sale Of PPE: 282164.00
CBAT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 2007812.00
CBAT income_statement (annual, 2022-12-31) — Selling General And Administration: 11745523.00
CBAT balance_sheet (annual, 2022-12-31) — Share Issued: 89135064.00
CBAT cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 23081272.00
CBAT cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -19815136.00
CBAT income_statement (annual, 2022-12-31) — Special Income Charges: -7218918.00
CBAT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 64193.00
CBAT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 117495374.00
CBAT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 103825153.00
CBAT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -147599.63
CBAT income_statement (annual, 2022-12-31) — Tax Provision: -1228207.00
CBAT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.10
CBAT balance_sheet (annual, 2022-12-31) — Taxes Receivable: 4292016.00
CBAT balance_sheet (annual, 2022-12-31) — Total Assets: 244032734.00
CBAT balance_sheet (annual, 2022-12-31) — Total Capitalization: 117495374.00
CBAT balance_sheet (annual, 2022-12-31) — Total Debt: 17623986.00
CBAT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 124378497.00
CBAT income_statement (annual, 2022-12-31) — Total Expenses: 253011170.00
CBAT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 119654237.00
CBAT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 118325726.00
CBAT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 7720380.00
CBAT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -11504603.00
CBAT income_statement (annual, 2022-12-31) — Total Other Finance Cost: -491060.00
CBAT income_statement (annual, 2022-12-31) — Total Unusual Items: -1508918.00
CBAT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1508918.00
CBAT balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 144206.00
CBAT balance_sheet (annual, 2022-12-31) — Treasury Stock: 4066610.00
CBAT balance_sheet (annual, 2022-12-31) — Work In Process: 17274033.00
CBAT balance_sheet (annual, 2022-12-31) — Working Capital: 13773151.00
CBAT income_statement (annual, 2022-12-31) — Write Off: 831132.00
CBAT income_statement (annual, 2023-12-31) — +Operating Expense: 30621104.00
CBAT income_statement (annual, 2023-12-31) — +Total Revenue: 204438365.00
CBAT balance_sheet (annual, 2023-12-31) — Accounts Payable: 26764807.00
CBAT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 26170047.00
CBAT balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 0.00
CBAT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -47765730.00
CBAT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 247465817.00
CBAT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3198249.00
CBAT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 12991278.00
CBAT balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 7739886.00
CBAT income_statement (annual, 2023-12-31) — Basic Average Shares: 89252085.00
CBAT income_statement (annual, 2023-12-31) — Basic EPS: -0.03
CBAT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 37356076.00
CBAT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 45843428.00
CBAT cash_flow (annual, 2023-12-31) — Capital Expenditure: -31140550.00
CBAT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2811158.00
CBAT balance_sheet (annual, 2023-12-31) — Capital Stock: 90063.00
CBAT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4643267.00
CBAT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4643267.00
CBAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 18615220.00
CBAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -42310384.00
CBAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 46506909.00
CBAT cash_flow (annual, 2023-12-31) — Change In Account Payable: 16785569.00
CBAT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2490859.00
CBAT cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 157434.00
CBAT cash_flow (annual, 2023-12-31) — Change In Inventory: 11207281.00
CBAT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
CBAT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 347511.00
CBAT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 7788975.00
CBAT cash_flow (annual, 2023-12-31) — Change In Payable: 16785569.00
CBAT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 14294710.00
CBAT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2050039.00
CBAT cash_flow (annual, 2023-12-31) — Change In Receivables: -2802713.00
CBAT cash_flow (annual, 2023-12-31) — Change In Tax Payable: 157434.00
CBAT cash_flow (annual, 2023-12-31) — Change In Working Capital: 28785725.00
CBAT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2960147.00
CBAT cash_flow (annual, 2023-12-31) — Changes In Cash: 22811745.00
CBAT balance_sheet (annual, 2023-12-31) — Common Stock: 90063.00
CBAT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 112824305.00
CBAT balance_sheet (annual, 2023-12-31) — Construction In Progress: 37797862.00
CBAT income_statement (annual, 2023-12-31) — Cost Of Revenue: 172714042.00
CBAT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6773906.00
CBAT balance_sheet (annual, 2023-12-31) — Current Assets: 128423485.00
CBAT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 2335856.00
CBAT balance_sheet (annual, 2023-12-31) — Current Debt: 32927228.00
CBAT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 35263084.00
CBAT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4034506.00
CBAT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4034506.00
CBAT balance_sheet (annual, 2023-12-31) — Current Liabilities: 160495555.00
CBAT balance_sheet (annual, 2023-12-31) — Current Provisions: 23870.00
CBAT cash_flow (annual, 2023-12-31) — Depreciation: 10335847.00
CBAT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10335847.00
CBAT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10335847.00
CBAT income_statement (annual, 2023-12-31) — Diluted Average Shares: 89252085.00
CBAT income_statement (annual, 2023-12-31) — Diluted EPS: -0.03
CBAT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -2449057.00
CBAT balance_sheet (annual, 2023-12-31) — Dividends Payable: 1256745.00
CBAT income_statement (annual, 2023-12-31) — EBIT: 1103219.00
CBAT income_statement (annual, 2023-12-31) — EBITDA: 11439066.00
CBAT income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -27428.00
CBAT cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 27428.00
CBAT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1345005.00
CBAT cash_flow (annual, 2023-12-31) — End Cash Position: 58822816.00
CBAT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 18615220.00
CBAT balance_sheet (annual, 2023-12-31) — Finished Goods: 20108440.00
CBAT cash_flow (annual, 2023-12-31) — Free Cash Flow: 15366359.00
CBAT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -136000.00
CBAT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CBAT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 544481.00
CBAT income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CBAT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 136000.00
CBAT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -10370892.00
CBAT income_statement (annual, 2023-12-31) — General And Administrative Expense: 13789108.00
CBAT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 12554064.00
CBAT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 29368296.00
CBAT balance_sheet (annual, 2023-12-31) — Gross PPE: 178276944.00
CBAT income_statement (annual, 2023-12-31) — Gross Profit: 31724323.00
CBAT income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 7070236.00
CBAT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 181611.00
CBAT balance_sheet (annual, 2023-12-31) — Interest Payable: 59524.00
CBAT balance_sheet (annual, 2023-12-31) — Inventory: 33413422.00
CBAT balance_sheet (annual, 2023-12-31) — Invested Capital: 145751533.00
CBAT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -42310384.00
CBAT balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 7739886.00
CBAT balance_sheet (annual, 2023-12-31) — Investments And Advances: 9666497.00
CBAT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 38022593.00
CBAT balance_sheet (annual, 2023-12-31) — Leases: 7214436.00
CBAT balance_sheet (annual, 2023-12-31) — Line Of Credit: 32587676.00
CBAT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 475302.00
CBAT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 475302.00
CBAT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1696857.00
CBAT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -884911.00
CBAT balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1926611.00
CBAT balance_sheet (annual, 2023-12-31) — Long Term Provisions: 522574.00
CBAT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 86336698.00
CBAT balance_sheet (annual, 2023-12-31) — Minority Interest: 634036.00
CBAT income_statement (annual, 2023-12-31) — Minority Interests: 6090270.00
CBAT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -4044175.00
CBAT balance_sheet (annual, 2023-12-31) — Net Debt: 28283961.00
CBAT income_statement (annual, 2023-12-31) — Net Income: -2449057.00
CBAT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2449057.00
CBAT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8539327.00
CBAT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2449057.00
CBAT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2449057.00
CBAT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8539327.00
CBAT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8539327.00
CBAT income_statement (annual, 2023-12-31) — Net Interest Income: 432900.00
CBAT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -7126798.00
CBAT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 18615220.00
CBAT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 811946.00
CBAT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 432900.00
CBAT balance_sheet (annual, 2023-12-31) — Net PPE: 130511214.00
CBAT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -31139411.00
CBAT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 17803274.00
CBAT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 100270241.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 0.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 6203488.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 6203488.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CBAT balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 7101492.00
CBAT income_statement (annual, 2023-12-31) — Normalized EBITDA: 22024177.00
CBAT income_statement (annual, 2023-12-31) — Normalized Income: 5489776.25
CBAT balance_sheet (annual, 2023-12-31) — Notes Receivable: 2483000.00
CBAT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 46506909.00
CBAT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 435909.00
CBAT income_statement (annual, 2023-12-31) — Operating Income: 1103219.00
CBAT income_statement (annual, 2023-12-31) — Operating Revenue: 204438365.00
CBAT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 89919190.00
CBAT balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 339552.00
CBAT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -10370892.00
CBAT balance_sheet (annual, 2023-12-31) — Other Equity Interest: 14101689.00
CBAT income_statement (annual, 2023-12-31) — Other Gand A: 13789108.00
CBAT income_statement (annual, 2023-12-31) — Other Income Expense: -7589301.00
CBAT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 12554064.00
CBAT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 3023238.00
CBAT balance_sheet (annual, 2023-12-31) — Other Payable: 85602883.00
CBAT balance_sheet (annual, 2023-12-31) — Other Properties: 1084520.00
CBAT balance_sheet (annual, 2023-12-31) — Other Receivables: 367404.00
CBAT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
CBAT balance_sheet (annual, 2023-12-31) — Payables: 114400189.00
CBAT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 121174095.00
CBAT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2208814.00
CBAT income_statement (annual, 2023-12-31) — Pretax Income: -6053182.00
CBAT balance_sheet (annual, 2023-12-31) — Properties: 0.00
CBAT income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 1284795.00
CBAT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1271730.00
CBAT cash_flow (annual, 2023-12-31) — Purchase Of Business: -4044175.00
CBAT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -7126798.00
CBAT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -31140550.00
CBAT balance_sheet (annual, 2023-12-31) — Raw Materials: 3779414.00
CBAT balance_sheet (annual, 2023-12-31) — Receivables: 33978433.00
CBAT balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -290228.00
CBAT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 172714042.00
CBAT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10335847.00
CBAT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -19407373.00
CBAT income_statement (annual, 2023-12-31) — Research And Development: 11928070.00
CBAT balance_sheet (annual, 2023-12-31) — Restricted Cash: 54179549.00
CBAT balance_sheet (annual, 2023-12-31) — Retained Earnings: -134395762.00
CBAT cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CBAT cash_flow (annual, 2023-12-31) — Sale Of PPE: 1139.00
CBAT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 4903926.00
CBAT income_statement (annual, 2023-12-31) — Selling General And Administration: 18693034.00
CBAT balance_sheet (annual, 2023-12-31) — Share Issued: 90063396.00
CBAT cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 36325736.00
CBAT cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -18522462.00
CBAT income_statement (annual, 2023-12-31) — Special Income Charges: -10721111.00
CBAT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1225747.00
CBAT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 112824305.00
CBAT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 100270241.00
CBAT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2646277.75
CBAT income_statement (annual, 2023-12-31) — Tax Provision: 2486145.00
CBAT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
CBAT balance_sheet (annual, 2023-12-31) — Taxes Receivable: 5248210.00
CBAT balance_sheet (annual, 2023-12-31) — Total Assets: 281155260.00
CBAT balance_sheet (annual, 2023-12-31) — Total Capitalization: 112824305.00
CBAT balance_sheet (annual, 2023-12-31) — Total Debt: 35738386.00
CBAT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 113458341.00
CBAT income_statement (annual, 2023-12-31) — Total Expenses: 203335146.00
CBAT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 167696919.00
CBAT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 152731775.00
CBAT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7201364.00
CBAT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7251812.00
CBAT income_statement (annual, 2023-12-31) — Total Other Finance Cost: -432900.00
CBAT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 775754.00
CBAT income_statement (annual, 2023-12-31) — Total Unusual Items: -10585111.00
CBAT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -10585111.00
CBAT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 144206.00
CBAT balance_sheet (annual, 2023-12-31) — Treasury Stock: 4066610.00
CBAT balance_sheet (annual, 2023-12-31) — Work In Process: 9525568.00
CBAT balance_sheet (annual, 2023-12-31) — Working Capital: -32072070.00
CBAT income_statement (annual, 2023-12-31) — Write Off: 3650875.00
CBAT income_statement (quarterly, 2024-09-30) — Basic Average Shares: 89931617.00
CBAT income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
CBAT cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: -339945.00
CBAT cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: -339945.00
CBAT cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
CBAT income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 90229849.00
CBAT income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
CBAT cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: -93.00
CBAT income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 93.00
CBAT balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 343856.00
CBAT cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 568.00
CBAT cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
CBAT cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: -10351163.00
CBAT income_statement (quarterly, 2024-09-30) — Provision For Doubtful Accounts: 546011.00
CBAT cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
CBAT cash_flow (quarterly, 2024-09-30) — Sale Of Business: 568.00
CBAT cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 376.00
CBAT cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 6327017.00
CBAT cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: -16678180.00
CBAT balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 144206.00
CBAT income_statement (quarterly, 2024-09-30) — Write Off: 546011.00
CBAT income_statement (annual, 2024-12-31) — +Operating Expense: 32155697.00
CBAT income_statement (annual, 2024-12-31) — +Total Revenue: 176614609.00
CBAT balance_sheet (annual, 2024-12-31) — Accounts Payable: 26317312.00
CBAT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 25728095.00
CBAT balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 92515.00
CBAT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -54469151.00
CBAT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 247842445.00